Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

[Utility of early imaging of myocardial innervation scintigraphy in the diagnosis of Lewy Body Dementia].

Camacho V, Estorch M, Marquié M, Domènech A, Flotats A, Fernández A, Duch J, Geraldo LL, Deportos J, Artigas C, Lleó A, Carrió I.

Rev Esp Med Nucl Imagen Mol. 2013 Mar;32(2):77-80. doi: 10.1016/j.remn.2012.03.012. Epub 2012 May 18. Spanish.

2.

[Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging].

Estorch M, Camacho V, Fuertes J, Rodríguez-Revuelto A, Hernández MA, Flotats A, Kulisevsky J, Carrió I.

Rev Esp Med Nucl. 2006 Jul-Aug;25(4):229-35. Spanish.

3.

Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life.

Estorch M, Camacho V, Paredes P, Rivera E, Rodríguez-Revuelto A, Flotats A, Kulisevsky J, Carrio I.

Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1636-41. doi: 10.1007/s00259-008-0828-8. Epub 2008 May 29.

PMID:
18509631
4.

Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features?

Sakamoto F, Shiraishi S, Tsuda N, Hashimoto M, Tomiguchi S, Ikeda M, Yamashita Y.

Br J Radiol. 2017 Feb;90(1070):20160156. doi: 10.1259/bjr.20160156. Epub 2016 Nov 29.

PMID:
27897064
5.
6.

Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.

Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, Urashima M, Inoue K.

J Neurol Sci. 2006 Jan 15;240(1-2):15-9. Epub 2005 Sep 29.

PMID:
16199056
8.

(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.

Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H.

Ageing Res Rev. 2016 Sep;30:122-33. doi: 10.1016/j.arr.2016.01.001. Epub 2016 Feb 2. Review.

PMID:
26835846
9.

[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].

Orimo S.

Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. Review. Japanese.

PMID:
18386627
10.

123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.

Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K.

Sleep. 2008 May;31(5):717-23.

11.

Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.

Camacho V, Marquié M, Lleó A, Alvés L, Artigas C, Flotats A, Duch J, Blesa R, Gómez-Isla T, Carrió I, Estorch M.

Q J Nucl Med Mol Imaging. 2011 Aug;55(4):476-83. Epub 2010 Dec 9.

PMID:
21150861
12.

Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies.

Kobayashi S, Tateno M, Morii H, Utsumi K, Saito T.

Psychiatry Res. 2009 Oct 30;174(1):76-80. doi: 10.1016/j.pscychresns.2009.02.006. Epub 2009 Sep 19.

PMID:
19766460
13.

Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.

Shimizu S, Hirao K, Kanetaka H, Namioka N, Hatanaka H, Hirose D, Fukasawa R, Umahara T, Sakurai H, Hanyu H.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):184-92. doi: 10.1007/s00259-015-3146-y. Epub 2015 Aug 2.

14.

(123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.

Kim JS, Park HE, Oh YS, Song IU, Yang DW, Park JW, Lee KS.

J Neurol Sci. 2015 Oct 15;357(1-2):173-7. doi: 10.1016/j.jns.2015.07.025. Epub 2015 Jul 17.

PMID:
26208800
15.

Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.

Slaets S, Van Acker F, Versijpt J, Hauth L, Goeman J, Martin JJ, De Deyn PP, Engelborghs S.

Int J Geriatr Psychiatry. 2015 Aug;30(8):864-9. doi: 10.1002/gps.4229. Epub 2014 Nov 3.

16.

(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.

Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C; SCILLA Working Group.

Ann Neurol. 2016 Sep;80(3):368-78. doi: 10.1002/ana.24717. Epub 2016 Aug 2.

PMID:
27398636
17.

Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.

Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakajima K, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Samuraki M, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamasaki J, Yamashina S, Yamada M.

PLoS One. 2015 Mar 20;10(3):e0120540. doi: 10.1371/journal.pone.0120540. eCollection 2015.

18.

Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.

Lebasnier A, Lamotte G, Manrique A, Peyronnet D, Bouvard G, Defer G, Agostini D.

Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1043-51. doi: 10.1007/s00259-015-2989-6. Epub 2015 Jan 28.

PMID:
25626701
19.

Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.

Yoshita M, Taki J, Yokoyama K, Noguchi-Shinohara M, Matsumoto Y, Nakajima K, Yamada M.

Neurology. 2006 Jun 27;66(12):1850-4.

PMID:
16801649
20.

Supplemental Content

Support Center